Roivant Sciences Ltd. ($ROIV)
Filing Information
| Accession Number | 0001635088-26-000065 |
|---|---|
| Form Type | 4 |
| Filing Date | May 22, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
634,483
Total Value
$7,941,594.03
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President & Immunovant CEO | Common Shares | โ | May 20, 2026 | Tax Withholding | 34,483 | $32.41 | $1,117,594.03 | 1,613,063 | Direct | โ | View Details | |
President & Immunovant CEO | Common Shares | โ | May 22, 2026 | Exercise/Conversion | 200,000 | $3.85 | $770,000.00 | 1,813,063 | Direct | โ | View Details | |
President & Immunovant CEO | Common Shares | โ | May 22, 2026 | Sale | 200,000 | $30.27 | $6,054,000.00 | 1,613,063 | Direct | โ | View Details | |
President & Immunovant CEO | Stock Option (Right to Buy) | Derivative | May 22, 2026 | Exercise/Conversion | 200,000 | $0.00 | $0.00 | 4,444,834 | Direct | โ | View Details |